• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肌肉-骨骼关系的更新版肌肉减少症概念。

Updated concept of sarcopenia based on muscle-bone relationship.

机构信息

Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.

出版信息

J Bone Miner Metab. 2020 Jan;38(1):7-13. doi: 10.1007/s00774-019-01048-2. Epub 2019 Oct 3.

DOI:10.1007/s00774-019-01048-2
PMID:31583540
Abstract

Sarcopenia is an age-related loss of skeletal muscle mass and strength. It has been widely recognized that low muscle mass was essential in the diagnosis of sarcopenia, whereas recent studies have emphasized the importance of muscle strength. In practice, muscle quality as well as muscle mass might determine the strength and physical performance. A new diagnostic algorithm of sarcopenia has recently been established, in which low muscle strength is a key characteristic factor for the diagnosis of sarcopenia. Although many factors are supposed to be involved in the pathology and development of sarcopenia, precise mechanisms remain to be elucidated. Recent studies have also focused on the crosstalk between muscles and bones, including functional involvement of myokines and osteokines.

摘要

肌肉减少症是一种与年龄相关的骨骼肌量和力量损失。人们普遍认为,低肌肉量是肌肉减少症诊断的关键,而最近的研究则强调了肌肉力量的重要性。实际上,肌肉质量以及肌肉量可能决定了力量和身体机能。最近已经建立了一种新的肌肉减少症诊断算法,其中肌肉力量低是诊断肌肉减少症的关键特征因素。尽管许多因素被认为与肌肉减少症的病理和发展有关,但确切的机制仍有待阐明。最近的研究还集中在肌肉和骨骼之间的相互作用上,包括肌肉因子和骨因子的功能参与。

相似文献

1
Updated concept of sarcopenia based on muscle-bone relationship.基于肌肉-骨骼关系的更新版肌肉减少症概念。
J Bone Miner Metab. 2020 Jan;38(1):7-13. doi: 10.1007/s00774-019-01048-2. Epub 2019 Oct 3.
2
[Clinical manifestation and pathophyisological bases of sarcopenia.].[肌肉减少症的临床表现及病理生理基础。]
Clin Calcium. 2016;26(12):1703-1708.
3
Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction.肌少症与脆性骨折:骨-肌肉相互作用的分子及临床证据
J Bone Joint Surg Am. 2015 Mar 4;97(5):429-37. doi: 10.2106/JBJS.N.00648.
4
Association Between the Decline in Muscle Health and the Decline in Bone Health in Older Individuals from the SarcoPhAge Cohort.老年人肌肉健康下降与骨骼健康下降之间的关联:SarcoPhAge 队列研究
Calcif Tissue Int. 2019 Mar;104(3):273-284. doi: 10.1007/s00223-018-0503-4. Epub 2018 Dec 3.
5
Sarcopenia and sarcopenic obesity.肌肉减少症和肌肉减少性肥胖症。
Korean J Intern Med. 2016 Nov;31(6):1054-1060. doi: 10.3904/kjim.2016.193. Epub 2016 Nov 1.
6
Pathogenesis and Management of Sarcopenia.肌肉减少症的发病机制与管理
Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002.
7
Bone health assessment in older people with or without muscle health impairment.老年人肌肉健康受损或未受损的骨骼健康评估。
Osteoporos Int. 2018 May;29(5):1057-1067. doi: 10.1007/s00198-018-4384-1. Epub 2018 Feb 14.
8
[Definition of sarcopenia and diagnostic evaluation in clinical practice].[临床实践中肌肉减少症的定义及诊断评估]
Rev Med Suisse. 2015 Mar 18;11(466):651-6.
9
Age-related skeletal muscle mass loss and physical performance in Taiwan: implications to diagnostic strategy of sarcopenia in Asia.台湾地区与年龄相关的骨骼肌量减少与身体机能表现:对亚洲地区肌少症诊断策略的启示。
Geriatr Gerontol Int. 2013 Oct;13(4):964-71. doi: 10.1111/ggi.12040. Epub 2013 Mar 3.
10
Jump test performance and sarcopenia status in men and women, 55 to 75 years of age.55 至 75 岁男性和女性的跳跃测试表现与肌肉减少症状况。
J Geriatr Phys Ther. 2014 Apr-Jun;37(2):76-82. doi: 10.1519/JPT.0b013e3182a51b11.

引用本文的文献

1
Special issue on sarcopenia: Asia-Pacific perspectives.肌肉减少症特刊:亚太地区视角
Osteoporos Sarcopenia. 2025 Jun;11(2 Suppl):1. doi: 10.1016/j.afos.2025.06.002. Epub 2025 Jun 19.
2
Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05.特立帕肽和阿仑膦酸钠对衰弱患者骨折预防效果的评估:日本骨质疏松症干预试验-05的亚组分析
J Bone Miner Metab. 2025 May 27. doi: 10.1007/s00774-025-01610-1.
3
Relationship between decreased activities of daily living, decreased physical strength and future weight loss in community-dwelling older adults.

本文引用的文献

1
Exercise Interventions for the Prevention and Treatment of Sarcopenia. A Systematic Umbrella Review.运动干预用于预防和治疗肌肉减少症。系统综述伞状评价。
J Nutr Health Aging. 2019;23(6):494-502. doi: 10.1007/s12603-019-1196-8.
2
Exercise-Induced Irisin, the Fat Browning Myokine, as a Potential Anticancer Agent.运动诱导的鸢尾素,一种促使脂肪褐变的肌动蛋白,作为一种潜在的抗癌剂。
J Obes. 2019 Apr 1;2019:6561726. doi: 10.1155/2019/6561726. eCollection 2019.
3
Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness.
社区居住的老年人日常生活活动能力下降、体力下降与未来体重减轻之间的关系。
Geriatr Gerontol Int. 2025 Mar;25(3):418-424. doi: 10.1111/ggi.15097. Epub 2025 Feb 4.
4
Muscle Performance as a Predictor of Bone Health: Among Community-Dwelling Postmenopausal Japanese Women from Setagaya-Aoba Study.肌肉性能作为骨骼健康的预测指标:来自世田谷-青叶研究的社区居住的绝经后日本女性。
Calcif Tissue Int. 2024 Oct;115(4):413-420. doi: 10.1007/s00223-024-01269-2. Epub 2024 Aug 6.
5
Skeletal muscle index based on CT at the 12th thoracic spine level can predict osteoporosis and fracture risk: a propensity score-matched cohort study.基于第12胸椎水平CT的骨骼肌指数可预测骨质疏松症和骨折风险:一项倾向评分匹配队列研究。
Front Med (Lausanne). 2024 Apr 25;11:1387807. doi: 10.3389/fmed.2024.1387807. eCollection 2024.
6
The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty.性激素在与年龄相关的肌肉减少症和衰弱的病理生理学中的作用。
Reprod Med Biol. 2024 Mar 11;23(1):e12569. doi: 10.1002/rmb2.12569. eCollection 2024 Jan-Dec.
7
High versus Low-Intensity Resistance Training on Bone Mineral Density and Content Acquisition by Postmenopausal Women with Osteopenia: A Randomized Controlled Trial.高强度与低强度抗阻训练对骨质减少的绝经后女性骨密度和骨量获取的影响:一项随机对照试验
Med J Islam Repub Iran. 2023 Nov 22;37:126. doi: 10.47176/mjiri.37.126. eCollection 2023.
8
Global epidemiological features and impact of osteosarcopenia: A comprehensive meta-analysis and systematic review.全球骨质减少性肌少症的流行病学特征及影响:一项全面的荟萃分析和系统综述。
J Cachexia Sarcopenia Muscle. 2024 Feb;15(1):8-20. doi: 10.1002/jcsm.13392. Epub 2023 Dec 12.
9
Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans.基于人类转录组学数据将已批准药物用于治疗少肌症
Pharmaceuticals (Basel). 2023 Apr 18;16(4):607. doi: 10.3390/ph16040607.
10
Osteopenia Is Associated with Shorter Survival in Patients with Intrahepatic Cholangiocarcinoma.骨量减少与肝内胆管癌患者的生存时间更短相关。
Curr Oncol. 2023 Feb 2;30(2):1860-1868. doi: 10.3390/curroncol30020144.
骨硬化蛋白抑制可缓解乳腺癌骨转移和肌肉无力。
JCI Insight. 2019 Apr 9;5(9):125543. doi: 10.1172/jci.insight.125543.
4
The Relation of Inflammaging With Skeletal Muscle Properties in Elderly Men.衰老与老年人骨骼肌特性的关系。
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319841934. doi: 10.1177/1557988319841934.
5
Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2.根据EWGSOP2标准,居住在积雪城市的日本社区老年人中肌肉减少症的患病率及危险因素
J Clin Med. 2019 Feb 28;8(3):291. doi: 10.3390/jcm8030291.
6
Characterization of a novel murine Sost ER Cre model targeting osteocytes.一种靶向骨细胞的新型小鼠Sost ER Cre模型的表征
Bone Res. 2019 Feb 21;7:6. doi: 10.1038/s41413-018-0037-4. eCollection 2019.
7
The Effect of β-hydroxy-β-methylbutyrate (HMB) on Sarcopenia and Functional Frailty in Older Persons: A Systematic Review.β-羟基-β-甲基丁酸(HMB)对老年人肌肉减少症和功能性虚弱的影响:系统评价。
J Nutr Health Aging. 2019;23(2):145-150. doi: 10.1007/s12603-018-1153-y.
8
The relationship between sarcopenia and fragility fracture-a systematic review.肌少症与脆性骨折的关系:系统综述。
Osteoporos Int. 2019 Mar;30(3):541-553. doi: 10.1007/s00198-018-04828-0. Epub 2019 Jan 4.
9
Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.鸢尾素通过αV 整合素受体介导对骨骼和脂肪的作用。
Cell. 2018 Dec 13;175(7):1756-1768.e17. doi: 10.1016/j.cell.2018.10.025.
10
Prevalence of frailty, cognitive impairment, and sarcopenia in outpatients with cardiometabolic disease in a frailty clinic.衰弱、认知障碍和肌肉减少症在衰弱诊所中心血管代谢疾病门诊患者中的患病率。
BMC Geriatr. 2018 Nov 6;18(1):264. doi: 10.1186/s12877-018-0955-4.